Posts in Article
RNA interference is hitting the market - Alnylam’s success heralds a new era for RNAi therapeutics

It has been a bumpy ride for RNA interference-based therapeutics. The protein-silencing phenomenon that shot into the spotlight with its 2006 Nobel Prize fell (aptly) quiet thereafter, suffering clinical disappointments and losing high-profile backing. But it is back with a bang: the first RNAi drug was FDA approved in August and a number of Big Pharma companies are striking deals with developers. Does this mark a watershed moment for RNAi therapeutics?

Read More
ArticleTobias
Health Technology  - The Digital Revolution: Part 2 Digitising Diabetes

Technological advances are permeating into the healthcare industry and are transforming the norns of patient care. The development of medical technology (MedTech) devices that can be used by clinicians, nurses, technicians and, most importantly, patients themselves is rapidly increasing. Such technologies are enabling greater access to patient data to monitor disease status and predict future health events. With tech giants such as Google and Apple diving into healthcare, only further acceleration of these patient-centred technologies can be expected, unlocking a wealth of patient data. Not only this, but the rise of wearables and mobile technologies has expedited the mass collation of health data.

Read More
ArticleTobias
Health Technology: The Digital Revolution - Part 1: AI & Imaging

Our era is witnessing a technological revolution. Healthcare is becoming increasingly digitised, empowering both patient and physician. We’re using computational power and data to better predict, diagnose and manage patients with complex health conditions. In part one of this series we explore AI and imaging and the effects these have on the diagnosis and treatment of cancer.

Read More
ArticleTobias